XML 44 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   18,957,366    
Beginning balance at Dec. 31, 2022 $ 17,667 $ 19 $ 149,233 $ (131,585)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 1,361   1,361  
Issuance of common stock for vested restricted stock units and earned performance stock units (in shares)   366,901    
Shares forfeited in exchange for withholding taxes (in shares)   (24,720)    
Shares forfeited in exchange for withholding taxes (57)   (57)  
Net loss (2,964)     (2,964)
Ending balance (in shares) at Sep. 30, 2023   19,299,547    
Ending balance at Sep. 30, 2023 16,007 $ 19 150,537 (134,549)
Beginning balance (in shares) at Jun. 30, 2023   19,251,920    
Beginning balance at Jun. 30, 2023 16,353 $ 19 150,159 (133,825)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 381   381  
Issuance of shares for vested restricted stock grants (in shares)   47,627    
Shares forfeited in exchange for withholding taxes (3)   (3)  
Net loss (724)     (724)
Ending balance (in shares) at Sep. 30, 2023   19,299,547    
Ending balance at Sep. 30, 2023 16,007 $ 19 150,537 (134,549)
Beginning balance (in shares) at Dec. 31, 2023   19,354,335    
Beginning balance at Dec. 31, 2023 17,276 $ 19 150,822 (133,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 865   865  
Stock option exercises, net of cashless exercises (in shares)   11,939    
Issuance of common stock for vested restricted stock units and earned performance stock units (in shares)   184,691    
Net loss (1,406)     (1,406)
Ending balance (in shares) at Sep. 30, 2024   19,550,965    
Ending balance at Sep. 30, 2024 16,735 $ 19 151,687 (134,971)
Beginning balance (in shares) at Jun. 30, 2024   19,492,702    
Beginning balance at Jun. 30, 2024 17,307 $ 19 151,422 (134,134)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 265   265  
Stock option exercises, net of cashless exercises (in shares)   7,064    
Issuance of shares for vested restricted stock grants (in shares)   51,199    
Net loss (837)     (837)
Ending balance (in shares) at Sep. 30, 2024   19,550,965    
Ending balance at Sep. 30, 2024 $ 16,735 $ 19 $ 151,687 $ (134,971)